Trials / Unknown
UnknownNCT04726943
RF Applications for Residual LAA Leaks
Radiofrequency Energy Applications Targeting Significant Residual Leaks After Left Atrial Appendage Occlusion
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Texas Cardiac Arrhythmia Research Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Although the clinical impact of residual left atrial appendage (LAA) leaks still requires confirmation, its patency resulting from incomplete LAA closure may promote blood stagnation and thrombus formation, and increase the risk of thromboembolic events. The main purpose of this trial is to evaluate the safety and efficacy of percutaneous leak closure with radiofrequency energy applications.
Detailed description
Therapies locally targeting the LAA via occlusion, exclusion, or excision have emerged as an alternative and effective approach for stroke prophylaxis in AF patients, especially those with OAC contra-indications. Despite mounting evidence of their safety and efficacy in comparison with standard oral therapy, device-related thrombus and incomplete LAA closure resulting in residual, significant leak may occur, potentially hindering an effective stroke prevention. Radiofrequency energy has been adopted in several settings (e.g., vascular, orthopedic, aesthetic surgery) to achieve thermal-induced tissue retraction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Radiofrequency Energy Applications | RF energy applications to the atrial edge of a leak resulting from incomplete LAA occlusion |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2022-02-01
- Completion
- 2022-12-31
- First posted
- 2021-01-27
- Last updated
- 2021-02-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04726943. Inclusion in this directory is not an endorsement.